Key Regulatory Elements of the TGFbeta-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types
Michael Cheng, Claire M. Storey, Mohamed Altai…·David Ulmert
Author
California NanoSystems InstituteORCID 0000-0001-9714-9001Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
5 papers
Recent·Most cited
Michael Cheng, Claire M. Storey, Mohamed Altai…·David Ulmert
Amit K Jaiswal, Georgia Scherer, Michelle L. Thaxton…·Dinesh S. Rao
This paper identifies I3IN-002, a small molecule inhibitor of IGF2BP3, which shows anti-leukemic activity in cell lines and a mouse model.
Claire M. Storey, Mohamed Altai, Katharina Lückerath…·David Ulmert
This paper develops a radio-theranostic approach targeting LRRC15 to image and treat cancer, showing tumor reduction and reversal of immunotherapy resistance.
Chandani Sen, Tammy M. Rickabaugh, Arjit Vijey Jeyachandran…·Brigitte N. Gomperts
This study uses a primary human stem cell-based airway model to screen 2100 compounds and identifies a small molecule effective against SARS-CoV-2 and its Omicron variant.
José O. Castellón, Constance Yuen, Brandon Han…·Keriann M. Backus
This study identifies caspase-10 inhibitors using an activation-based high-throughput screen, revealing inhibitors that preferentially target the zymogen form of caspase-10.